Charles O’Shaughnessy, MD, FACC, FAHA, FSCAI, is an interventional cardiologist at University Hospitals Harrington Heart & Vascular Institute, directing cardiac catheterization services at University Hospitals Elyria Medical Center.
Dr. O’Shaughnessy earned his medical degree from the Medical College of Ohio in Toledo. His postdoctoral training included a residency in internal medicine at Akron City Hospital followed by a fellowship in cardiovascular disease at University Hospitals of Cleveland. He is board certified in both internal medicine and cardiovascular disease.
In addition to his clinical practice, Dr. O’Shaughnessy has 20 years of service as a member of multiple scientific advisory boards and speaker bureaus related to innovations in percutaneous coronary interventions. He has also been very active in medical research over the past 30 years with participation in nearly 80 clinical studies that evaluated the effectiveness of various medications and minimally invasive interventions to treat coronary artery disease. He has made contributions to the medical field with publications as well, authoring a significant number of articles in prominent journals including the New England Journal of Medicine, Journal of Invasive Cardiology, Journal of the American College of Cardiology, Cardiovascular Interventions, European Heart Journal and more.
Dr. O’Shaughnessy is a member of respected national organizations including the American College of Physicians and American Heart Association. He is a fellow of the American College of Cardiology (ACC), Council of Clinical Cardiology in the American Heart Association and the Society of Cardiac Angiography and Intervention (SCAI).
Dr. O’Shaughnessy has dedicated most of his medical career to serving patients in Elyria and surrounding communities as part of North Ohio Heart. He has extensive experience in the diagnosis and treatment of patients with both common and complex heart conditions, including coronary artery disease, heart arrythmias such as atrial fibrillation and heart valve disease.
Dr. O’Shaughnessy has been recognized as a Top Doctor by Cleveland Magazine, a Best Doctor in America by Castle Connolly and a Strathmore’s Who’s Who.
Certifications & Memberships
- Interventional Cardiology - American Board of Internal Medicine
- Cardiovascular Disease - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Fellowship | Cardiovascular Disease
Cardiovascular Disease - University Hospitals Of Cleveland (1979 - 1981)
Residency | Internal Medicine
Internal Medicine - Akron City Hospital (Summa Health System) (1976 - 1979)
Medical College Of Ohio (1976)
Ohio University (1972)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Charles O'Shaughnessy disclosed the following Outside Relationships with Industry:
- - AstraZeneca - Honoraria